NovaBridge Biosciences American Depositary Shares
NBP
48 hedge funds and large institutions have $448M invested in NovaBridge Biosciences American Depositary Shares in 2020 Q3 according to their latest regulatory filings, with 29 funds opening new positions, 8 increasing their positions, 5 reducing their positions, and 1 closing their positions.
2,800% more first-time investments, than exits
New positions opened: 29 | Existing positions closed: 1
400% more funds holding in top 10
Funds holding in top 10: 1 → 5 (+4)
222% more capital invested
Capital invested by funds: $139M → $448M (+$308M)
140% more funds holding
Funds holding: 20 → 48 (+28)
60% more repeat investments, than reductions
Existing positions increased: 8 | Existing positions reduced: 5
6.2% more ownership
Funds ownership: 6% → 12.21% (+6.2%)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
HA
HHLR Advisors
Grand Cayman,
Cayman Islands
|
+$49.3M |
| 2 |
APM
Avidity Partners Management
Dallas,
Texas
|
+$44.2M |
| 3 |
O
OrbiMed
New York
|
+$20M |
| 4 |
AG
Artal Group
Luxembourg
|
+$13.2M |
| 5 |
SFM
Sphera Funds Management
Tel Aviv,
Israel
|
+$5.99M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
SLC
Snow Lake Capital
Central,
Hong Kong
|
-$6.44M |
| 2 |
SCM
Sio Capital Management
New York
|
-$3.41M |
| 3 |
CS
Candriam SCA
Strassen, Luxembourg,
Luxembourg
|
-$977K |
| 4 |
Morgan Stanley
New York
|
-$441K |
| 5 |
SG Americas Securities
New York
|
-$432K |
NBP Hedge Fund Activity: Q3 2020 in Review
48 of the 4,970 institutional investors tracked by Wall St. Rank reported a position in NovaBridge Biosciences American Depositary Shares (NBP) for Q3 2020, worth a combined $448M — up 222% from $139M a quarter earlier.
Buyers outnumbered sellers: 29 funds opened new NBP positions and 1 closed out — a net gain of 28 holders — while 8 added to existing stakes and 5 trimmed.
The largest buyer was HHLR Advisors, opening a new position worth an estimated $49.3M. The largest seller was Snow Lake Capital, cutting an estimated $6.44M.
- 48 institutional investors held NovaBridge Biosciences American Depositary Shares (NBP) as of Q3 2020, up from 20 in Q2 2020.
- Funds reported $448M of NovaBridge Biosciences American Depositary Shares stock for Q3 2020, up 222% quarter-over-quarter.
- 29 funds opened new NovaBridge Biosciences American Depositary Shares positions in Q3 2020 and 1 closed out, a net change of +28 holders.
- The largest NovaBridge Biosciences American Depositary Shares buyer in Q3 2020 was HHLR Advisors, an estimated $49.3M added.
- The largest NovaBridge Biosciences American Depositary Shares seller in Q3 2020 was Snow Lake Capital, an estimated $6.44M sold.
Based on aggregated 13F filings for Q3 2020.